Mirae Asset Sharekhan

Mirae Asset Sharekhan

OPEN DEMAT ACCOUNT

LOGIN / TRADE OPEN ACCOUNT

Follow Us :

Sharekhan

BUY NOW Buy Vivanza Biosciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Overview
Market Data
Market Depth
Option Chain
News
Fundamental
Shareholding Pattern
Corporate Action
Peers
Company Info
FAQ’s

Home Stock Vivanza Biosciences Ltd

Wed 21/05/2025,16:1:0

NSE

BSE

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 2.94

Previous Close

₹ 2.69

Volume

207291

Mkt Cap ( Rs. Cr)

₹11.24

High

₹ 2.94

Low

₹ 2.75

52 Week High

₹ 7.38

52 Week Low

₹ 1.90

Book Value Per Share

₹ 1.23

Dividend Yield

0.00

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Vivanza Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vivanza Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

Vivanza Biosciences - Newspaper Publication

14 May 2025, 3:56PM Newspaper Publication - The extract of Audited Standalone and Consolidated Financial Results for the Quarter and Financial year ended on March 31, 202
Vivanza Biosciences - Clarification On Typographical Error

13 May 2025, 2:50PM Revised Outcome of the Board Meeting pertaining to clarification on Typographical Error in the Notes related to Financial Results submission for the q
Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Change in Management

12 May 2025, 6:51PM Appointment of Mr. Hitesh Pradeep Rijwani (DIN: 11030634) as Additional Director (Non- Executive, Independent Director)
Vivanza Biosciences - Audited Financial Result For The Quarter And Financial Year Ended On 31St March, 2025

12 May 2025, 6:45PM Audited Standalone and Consolidated Financial Results along with Audit Report of the Company for the Quarter and Financial Year ended 31st March, 2025
Vivanza Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Held Today 12Th May, 2025

12 May 2025, 6:35PM The Board of Directors of the Company at its meeting held today i.e. Monday, 12th May, 2025 at Registered Office of the Company has inter alia conside
Vivanza Biosciences - Board Meeting Intimation for The Quarter And Financial Year Ended March 31, 2025.

6 May 2025, 3:56PM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider
Vivanza Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

15 Apr 2025, 6:51PM As of March 2025, 20.02% is owned by Indian Promoters and 79.98% by Public. <p align=justify> Top two Promoters holding highest number of shares of Vi
Vivanza Biosciences - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligatio

11 Apr 2025, 4:37PM Non-applicability of Statement of Deviation or variation under Regulation 32 of SEBI (LODR) Regulations, 2015
Vivanza Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

3 Apr 2025, 11:29AM Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended 31st March, 2025.
Vivanza Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

2 Apr 2025, 5:59PM In compliance with Reg. 74(5) of SEBI(Depositories and Participants) Regulations 2018 we are enclosing herewith a copy of certificate received from Pu
Vivanza Biosciences - Appointment of Company Secretary and Compliance Officer

20 Mar 2025, 4:30PM APPOINTMENT OF MS. SIDDHI SHAH AS A COMPANY SECRETARY & COMPLIANCE OFFICER W.E.F 20TH MARCH, 2025.
Vivanza Biosciences - Board Meeting Outcome for Appointment Of Company Secretary

20 Mar 2025, 4:15PM Appointment of Ms. Siddhi Shah as Company Secretary w.e.f. 20.03.2025
Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Resignation of Director

11 Mar 2025, 6:29PM Disclosure under Regulation 30 of SEBI (LODR) regarding intimation of Mr. Aagam Shah (DIN: 10602386), Independent Director of the Company.

Key fundamentals

Evaluate the intrinsic value of Vivanza Biosciences Ltd stock

Name	March-25	March-24	March-23	March-22	March-21
Assets	10.113	7.9781	10.9623	5.5128	3.5404
Liabilities	10.113	7.9781	10.9623	5.5128	3.5404
Equity	4	4	4	4	4
Gross Profit	-0.3635	0.7998	0.7212	0.049	0.1259
Net Profit	-0.6951	0.3174	0.5691	0.4636	0.0998
Cash From Operating Activities	-2.4688	1.7835	0.1607	-0.6771	-3.0778
NPM(%)	-23.62	2.2	4	5.06	1.08
Revenue	2.9428	14.4132	14.2071	9.1475	9.2233
Expenses	3.3063	13.6134	13.4859	9.0984	9.0973
ROE(%)	-14.12	6.45	11.56	9.42	2.02

Shareholding Pattern

Corporate Action

XD-Date	Dividend-Amount	Dividend-%	Dividend Yield(%GE)	Price on that day

From Year	To Year	Class of Share	Authorized Capital(Crores)	Issued Capital(Crores)	Paid Up Shares(NOS)	Paid Up Face Value	Paid Up Capital(Crores)
2023	2024	Equity Share	4.00	4.00	40000000.00	1	4.00
2022	2023	Equity Share	4.00	4.00	40000000.00	1	4.00
2021	2022	Equity Share	4.00	4.00	4000000.00	10	4.00
2020	2021	Equity Share	4.00	4.00	4000000.00	10	4.00
2019	2020	Equity Share	4.00	4.00	4000000.00	10	4.00
2018	2019	Equity Share	4.00	4.00	4000000.00	10	4.00
2017	2018	Equity Share	4.00	4.00	4000000.00	10	4.00
2016	2017	Equity Share	4.00	4.00	4000000.00	10	4.00
2015	2016	Equity Share	4.00	0.19	188000.00	10	0.19
2014	2015	Equity Share	4.00	3.76	3760000.00	10	3.76
2013	2014	Equity Share	4.00	3.76	3760000.00	10	3.76
2012	2013	Equity Share	4.00	3.76	3760000.00	10	3.76
2011	2012	Equity Share	4.00	3.76	3760000.00	10	3.76
2010	2011	Equity Share	4.00	3.76	3760000.00	10	3.76
2009	2010	Equity Share	4.00	3.76	3760000.00	10	3.76
2001	2002	Equity Share	4.00	3.76	3760000.00	10	3.76
1999	2000	Equity Share	4.00	3.76	3760000.00	10	3.76
1996	1999	Equity Share	4.00	3.76	3760000.00	10	3.76
1995	1996	Equity Share	4.00	3.76	3760000.00	10	3.76

Announcement Date	Price	Bonus Ratio	Record Date

Fund	Market Value(CR)	% Hold
No Records Found

Peers

Other companies within the same industry or sector that are comparable to Vivanza Biosciences Ltd

Company	Price	Price (% change)	pe(x)	EV/EBITDA(x)	ROE(%)	ROCE(%)
Albert David Ltd	810.05	-1.12	26.88	1.54	301.39	0.62
Lotus Eye Hospital and Institute Ltd	74.39	0.39	308.58	5.59	14.01	0.68
Bharat Immunological and Biologicals Corporation Ltd	25.66	-5.45	0.00	11.62	-39.50	0.00
Astec Lifesciences Ltd	698.00	-1.87	0.00	5.27	-687.11	0.00

Company Info

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Read More

Parent Organisation

Vivanza Biosciences Ltd.

Founded

06/03/1982

Managing Director

Mr.J A Mehta

NSE Symbol

FAQ

The current price of Vivanza Biosciences Ltd is ₹ 2.81.

The 52-week high for Vivanza Biosciences Ltd is

The market capitalization of Vivanza Biosciences Ltd is currently ₹ 11.24. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vivanza Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vivanza Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vivanza Biosciences Ltd shares.

The CEO of Vivanza Biosciences Ltd is Mr.J A Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT